SCHEMBL17547795

SCHEMBL17547795

CC(C)c1c(-c2cnn(Cc3ccc(Oc4ccccc4)cc3)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
KDM5B Q9UGL1 5/20 0.43
KDM5A P29375 10/20 0.41
MAP2K1 Q02750 1/20 0.39
KDM5C P41229 2/20 0.38
ADORA2B P29275 3/20 0.38
ADORA3 P0DMS8 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
GRM2 Q14416 1/20 0.37
KDM6B O15054 1/20 0.36
KDM5D Q9BY66 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
PHF8 Q9UPP1 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17547794 0.93 KDM5B (0.42) CYP11B1CYP11B2KDM5BKDM5AMAP2K1
SCHEMBL16092313 0.92 KDM5B (0.50) CYP11B1CYP11B2KDM5BKDM5AADORA2B
SCHEMBL16092356 0.91 KDM5B (0.46) KDM5BKDM5AKDM5CADORA2BADORA3
SCHEMBL17547803 0.91 RET (0.43) CYP11B1CYP11B2KDM5BKDM5AKDM5C
SCHEMBL17547809 0.88 CREBBP (0.41) CYP11B1CYP11B2KDM5BKDM5AMAP2K1
SCHEMBL17547840 0.87 KDM5A (0.48) KDM5BKDM5AMAP2K1KDM5CGRM2
SCHEMBL16092324 0.87 CREBBP (0.44) KDM5BKDM5AKDM5CADORA2BADORA3
SCHEMBL17547793 0.86 KDM5B (0.51) KDM5BKDM5AKDM5CADORA2BADORA3
SCHEMBL17547791 0.86 ADORA2B (0.46) KDM5BKDM5AADORA2BADORA3ADORA2A
SCHEMBL17547800 0.85 KDM5B (0.44) KDM5BKDM5AKDM5CADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B CYP11B1 651/4885CYP11B2 600/4885KDM5B 3/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B CYP11B1 651/4885CYP11B2 600/4885KDM5B 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.